Influenza A and influenza B produce nearly identical symptoms — sudden-onset fever, body aches, headache, dry cough, sore throat, and profound fatigue — but they differ in how they spread, who they affect most, and how aggressively they circulate each season. Influenza A is responsible for the majority of adult hospitalizations and all historical pandemics; influenza B typically drives a later-season wave and disproportionately affects children. At TrufaMED in Surfside, our multiplex respiratory panel identifies the specific strain within minutes so treatment can begin the same visit.
The Core Difference Between Influenza A and B
Influenza A and B are separate genera of the influenza virus family. Both cause seasonal flu, but their biology diverges in clinically meaningful ways:
- Influenza A infects humans, birds, pigs, and other mammals. It is classified by surface proteins hemagglutinin (H) and neuraminidase (N), producing subtypes such as H1N1 and H3N2. Because it reassorts across species, only influenza A causes pandemics.
- Influenza B infects only humans and seals. It does not have subtypes; instead, it circulates as two lineages, Victoria and Yamagata. Since 2020, the Yamagata lineage has been largely absent from global surveillance, and current vaccines are trivalent rather than quadrivalent.
For the 2025–2026 respiratory season, the CDC reports that H3N2 has been the dominant strain in the southeastern United States, with influenza B/Victoria activity rising through late winter and early spring.
Current 2026 Influenza Symptoms
Symptom overlap between the two types is the rule rather than the exception. Both present with an abrupt, rather than gradual, onset:
- Fever of 100°F to 104°F, often with chills
- Dry cough
- Sore throat
- Muscle and joint aches, often severe
- Headache
- Profound fatigue and weakness
- Nasal congestion
- Gastrointestinal symptoms — vomiting and diarrhea — more common with influenza B, particularly in children
The classic clinical distinction — that influenza A is always more severe — is an oversimplification. Severe influenza B is well-documented, and every season produces pediatric deaths from both types.
Flu B Symptoms: What’s Different
Influenza B tends to produce more gastrointestinal symptoms than influenza A and is associated with a higher rate of myositis (muscle inflammation) in children, which can present as calf pain and difficulty walking. Pediatric patients with influenza B are also at greater risk of developing secondary bacterial otitis media. Adults with influenza B generally recover along the same timeline as influenza A, though elderly patients can still develop viral pneumonia and cardiac complications from either type.
Transmission and Incubation
Both types spread through respiratory droplets and close contact. The incubation period is 1 to 4 days (average 2 days), shorter than COVID-19. Patients are contagious from roughly 1 day before symptom onset through 5 to 7 days after, with young children and immunocompromised patients shedding virus longer.
Who Is at Higher Risk of Complications
The highest-risk populations are essentially the same for both types:
- Adults aged 65 and older
- Children under 5, particularly those under 2
- Pregnant patients and those within 2 weeks postpartum
- Patients with asthma, COPD, or other chronic lung disease
- Patients with heart disease, diabetes, or chronic kidney disease
- Immunocompromised patients
- Adults with obesity (BMI >40)
- Residents of long-term care facilities
When to Seek Urgent Care
Most healthy adults recover at home, but you should be evaluated promptly if you experience:
- Difficulty breathing or shortness of breath
- Persistent chest pain or pressure
- Fever above 103°F that does not respond to medication
- Symptoms that improve and then worsen (suggesting bacterial superinfection)
- Severe dehydration or inability to tolerate fluids
- Confusion or altered mental status
- Any fever in an infant under 3 months of age
Diagnosis: Why Strain Identification Matters
Clinical examination cannot reliably distinguish influenza A from B or from COVID-19, RSV, and strep throat. At TrufaMED, we use a multiplex molecular panel that identifies all four pathogens from a single nasal swab within approximately 20 minutes. Accurate identification directly changes treatment:
- Confirming influenza allows for appropriate antiviral prescribing and avoids unnecessary antibiotics
- Identifying specific strains informs public health reporting and close-contact prophylaxis
- Excluding bacterial causes such as strep throat prevents overtreatment
Learn more about our combined COVID, flu, strep, and RSV testing panel.
Treatment Options in 2026
Antiviral therapy is most effective when started within 48 hours of symptom onset. Both influenza A and B respond to the same agents:
- Oseltamivir (Tamiflu) — oral; the standard of care for most adults and children older than 2 weeks
- Baloxavir (Xofluza) — single-dose oral therapy for patients 5 years and older; convenient but with emerging resistance concerns, particularly against influenza A/H3N2
- Zanamivir (Relenza) — inhaled; contraindicated in patients with asthma or COPD
- Peramivir (Rapivab) — intravenous single-dose option for patients unable to take oral medications
Supportive care — hydration, acetaminophen or ibuprofen for fever and body aches, rest — remains essential. Patients with severe dehydration or prolonged fatigue often benefit from IV hydration therapy to accelerate recovery. Our flu treatment protocol is reviewed by a physician at every visit.
Recovery Timeline
Fever typically breaks by day 3 to 5. Cough and fatigue can persist for 1 to 2 weeks. Return to intense exercise should be gradual; influenza-associated myocarditis is rare but well-documented and can be precipitated by premature return to strenuous activity.
Prevention
The CDC recommends annual influenza vaccination for all patients aged 6 months and older, ideally by the end of October but beneficial throughout the season. The 2025–2026 vaccine is trivalent, targeting H1N1, H3N2, and B/Victoria. Additional prevention measures include hand hygiene, avoiding close contact with symptomatic individuals, and staying home when ill.
Related Respiratory Conditions
Because flu, COVID, RSV, and strep throat can present similarly, particularly early in illness, testing is the only reliable way to confirm the cause. Pediatric patients with influenza-like illness should be evaluated by a clinician experienced in pediatric care; our pediatric urgent care team is available seven days a week.
Frequently Asked Questions
Which is worse, influenza A or B?
On average, influenza A causes more severe illness and the majority of adult hospitalizations. However, influenza B can be equally severe in children and in the elderly.
Can you have both influenza A and B in the same season?
Yes. Because immunity from one type does not protect against the other, back-to-back infections within a single season are well-documented.
How long does the flu last?
Fever usually resolves within 3 to 5 days. Cough and fatigue commonly persist for 1 to 2 weeks. Antivirals can shorten symptoms by 24 to 48 hours if started early.
Is the flu shot effective against both types?
Yes. The 2025–2026 vaccine covers both influenza A subtypes and influenza B/Victoria.
When should I start Tamiflu?
Ideally within 48 hours of symptom onset. Beyond 48 hours, benefit diminishes but may still be worthwhile in high-risk patients.
Is flu B more common in children?
Children are more susceptible to influenza B and tend to experience more gastrointestinal symptoms and muscle inflammation than adults.
Can you get the flu more than once in a year?
Yes. Infection with influenza A does not provide cross-protection against influenza B, and strain drift within a single type can also allow reinfection.
Same-Day Flu Testing at TrufaMED
If you or a family member has flu-like symptoms, confirming the diagnosis within the first 48 hours is the single most important factor in deciding whether antivirals are appropriate. TrufaMED is open seven days a week, 8 a.m. to 10 p.m., with a physician on site every day. Walk in at 9445 Harding Avenue in Surfside or call (305) 537-6396 to be seen the same day.
Sources: Centers for Disease Control and Prevention (CDC) FluView weekly surveillance reports. Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines on Seasonal Influenza.
